anyone else notice API source kicking in around week 89
I have had 7 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 8 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 99.0% against a claimed 99.1%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
Did they tell you their API source or dodge the question?
no pharmacy referral codes, naming is fine, recruiting is not
state board rules differ, say which state
Are we talking 503A or 503B?
API transparency is the question that separates good compounders from sketchy ones
API transparency is the question that separates good compounders from sketchy ones
Yes, exactly this, and it is the bit that took me 78 weeks to accept.
telehealth costs compounding plus compounding markup, total varies
the shortage list is temporary, it ends and compounding becomes illegal again
[deleted]
telehealth prescriber models exist, pricing differs by state
This is the "correlation is mechanism" thing again. You changed three variables at once.
telehealth prescriber models exist, pricing differs by state
Strongly agree. API source transparency matters.
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
503B compounding is different from 503A, different rules, different legality
telehealth prescriber models exist, pricing differs by state
the 503A/503B distinction is load-bearing, do not blur it
That is net peptide content, not purity. Different number, different meaning.
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.
API transparency is the question that separates good compounders from sketchy ones
Not convinced. The evidence does not support that reading.
the shortage list is temporary, it ends and compounding becomes illegal again
Not convinced.
Yes, exactly this, and it is the bit that took me 25 weeks to accept.
Every time this gets posted it hits the front page and every time someone has to re-explain it.
Yeah, 503A and 503B are different regulatory animals.
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the shortage list is temporary, it ends and compounding becomes illegal again
- 1Strongly agree. API source transparency matters.11 comments in this branch · started by u/bruno_dumitru
- 2telehealth costs compounding plus compounding markup, total varies7 comments in this branch · started by u/tobias_vukovic